{"id":45638,"date":"2022-06-29T15:01:55","date_gmt":"2022-06-29T13:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/"},"modified":"2022-06-29T15:01:55","modified_gmt":"2022-06-29T13:01:55","slug":"tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/","title":{"rendered":"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Article highlights promising preliminary results and path forward for FDA-approved stem cell treatment study<\/i>\n<\/p>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;The Tisch<b> <\/b>Multiple Sclerosis Research Center of New York, the world\u2019s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace.\n<\/p>\n<p>\nPreliminary analysis of the study results found that stem cell treatments substantially improved muscle strength and disability scores, particularly among patients with lower levels of disability. Interviewing Dr. Saud A. Sadiq, the Director and Chief Research Scientist of the Tisch MSRCNY, as well as Senior Research Scientist Dr. Violaine Harris, the article features the progress and key results of the stem cell treatment study, as well as the broader history and goals of the center.\n<\/p>\n<p>\n\u201cWe are excited to share more about our stem cell treatment research, which is a key study in service of our center\u2019s overarching goal of finding the cause of and the cure for MS,\u201d said Dr. Sadiq. \u201cFurthermore, the study has enormous potential not only for the treatment of MS patients, but also promising potential implications for those with other neurodegenerative diseases. We\u2019re delighted to share our analysis with the broader public and scientific community, and look forward to sharing further updates on this groundbreaking research as it progresses.\u201d\n<\/p>\n<p>\nThe full BioSpace article can be accessed <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cnn.com%2F2022%2F06%2F03%2Fentertainment%2Fjamie-lynn-sigler-ms%2Findex.html&amp;esheet=52764956&amp;newsitemid=20220629005121&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=dfb9d41c680ba8d341df2570661f3046\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\n<b>About the Tisch MS Research Center of New York<\/b>\n<\/p>\n<p>\nThe mission of the Tisch Multiple Sclerosis Research Center of New York is to conduct groundbreaking medical research to ensure unparalleled care and positive outcomes for MS patients. Its integrated relationship with the International Multiple Sclerosis Management Practice (IMSMP) accelerates the pace at which research discoveries translate from lab bench to bedside. The Center aims to identify the cause of MS, understand disease mechanisms, optimize therapies, and repair the damage caused by MS while offering patients access to the best and most advanced treatments possible.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKerry Close<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6b;c&#x6c;o&#x73;e&#x40;g&#114;&#x6f;&#117;&#x70;&#103;&#x6f;&#114;&#x64;&#111;&#x6e;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#x63;&#x6c;&#x6f;&#x73;&#x65;&#64;&#103;&#114;&#111;upgo&#x72;&#x64;&#x6f;&#x6e;&#x2e;&#x63;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Article highlights promising preliminary results and path forward for FDA-approved stem cell treatment study NEW YORK&#8211;(BUSINESS WIRE)&#8211;The Tisch Multiple Sclerosis Research Center of New York, the world\u2019s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace. Preliminary analysis of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45638","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Article highlights promising preliminary results and path forward for FDA-approved stem cell treatment study NEW YORK&#8211;(BUSINESS WIRE)&#8211;The Tisch Multiple Sclerosis Research Center of New York, the world\u2019s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace. Preliminary analysis of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-29T13:01:55+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace\",\"datePublished\":\"2022-06-29T13:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/\"},\"wordCount\":341,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/\",\"name\":\"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-06-29T13:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/","og_locale":"en_US","og_type":"article","og_title":"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Pharma Trend","og_description":"Article highlights promising preliminary results and path forward for FDA-approved stem cell treatment study NEW YORK&#8211;(BUSINESS WIRE)&#8211;The Tisch Multiple Sclerosis Research Center of New York, the world\u2019s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace. Preliminary analysis of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-29T13:01:55+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace","datePublished":"2022-06-29T13:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/"},"wordCount":341,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/","url":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/","name":"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-06-29T13:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tisch-multiple-sclerosis-research-center-of-new-york-study-featured-in-biospace\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45638"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45638\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}